Opinion
Video
An Overview of Fusion-Guided Systems
Author(s):
A urologic oncologist discusses how MRI- or fusion-guided biopsies have helped overcome the limitations of traditional prostate biopsies.
Video Player is loading.
Video content above is prompted by the following questions:
- What is the difference between software and cognitive fusion? Why might you prefer one over the other? Are all systems the same?
- A recent study indicated that detection rates were similar. Have you found that to be true in clinical practice?
- What are key differences between rigid fusion and elastic fusion? Between organ-based tracking and probe tracking technologies?
Related Videos
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
What a long-term study of patients undergoing RARC reveals about upstaging
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
Neeraja Tillu, MD, discusses predictors of upstaging following RARC for NMIBC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Neeraj Agarwal, MD, outlines data on enzalutamide plus talazoparib in mCRPC
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
Alicia Morgans, MD, MPH, on PSADT awareness and prostate cancer treatment initiation
Related Content
